Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer
Clinical trial NCT00100672 · COMPLETED
Trial details
- NCT number
- NCT00100672
- Sponsor
- INSYS Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2009-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.